Connected profileLeuprolide
Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
leuprolide acetate clinical trials
14 selected ClinicalTrials.gov records carrying the official matched intervention leuprolide acetate (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
Registry records
14 selected records.
Connected peptides
1 profiles.
Source boundary
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 46 selected PubMed records and 24 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
Record added
ClinicalTrials.gov record NCT05896293
PeptideScanner retained ClinicalTrials.gov record NCT05896293 at 2026-08-10T18:10:03.920Z. Its registry update date was 2026-07-13, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 14, 2026
- Cited source date
- July 13, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00002580
PeptideScanner retained ClinicalTrials.gov record NCT00002580 at 2026-07-30T21:55:56.626Z. Its registry update date was 2013-11-06, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- November 6, 2013
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT00002582
PeptideScanner retained ClinicalTrials.gov record NCT00002582 at 2026-07-30T21:55:56.631Z. Its registry update date was 2013-08-02, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- August 2, 2013
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Leuprolide · 2026-07-13
ClinicalTrials.gov record NCT05896293
Recruiting at the retained observation.
Open attributed record →Leuprolide · 2017-06-06
ClinicalTrials.gov record NCT01023061
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-06-01
ClinicalTrials.gov record NCT00225420
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-05-30
ClinicalTrials.gov record NCT01431391
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-05-25
ClinicalTrials.gov record NCT00943956
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-02-10
ClinicalTrials.gov record NCT00454571
Completed at the retained observation.
Open attributed record →Leuprolide · 2014-01-06
ClinicalTrials.gov record NCT00003124
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-11-06
ClinicalTrials.gov record NCT00002580
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-08-02
ClinicalTrials.gov record NCT00002582
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-06-24
ClinicalTrials.gov record NCT00003394
Completed at the retained observation.
Open attributed record →Leuprolide · 2012-03-19
ClinicalTrials.gov record NCT00653757
Completed at the retained observation.
Open attributed record →Leuprolide · 2012-01-27
ClinicalTrials.gov record NCT00805935
Completed at the retained observation.
Open attributed record →Leuprolide · 2010-11-09
ClinicalTrials.gov record NCT00002881
Completed at the retained observation.
Open attributed record →Leuprolide · 2005-06-24
ClinicalTrials.gov record NCT00004311
Completed at the retained observation.
Open attributed record →